Nivolumab and Tumor Infiltrating Lymphocytes (TIL) in Advanced Non-Small Cell Lung Cancer

Demographics (3)

Race and Ethnicity (1)

Other (22)

  • AFFECTION_STATUS - Case control status of the subject for metastatic non-small cell lung cancer (phv00492787.v1.p1)
  • ANALYTE_TYPE - Type of sequencing for this sample (phv00492805.v2.p1)
  • BODY_SITE - Body site where sample was collected; LN=lymph_node (phv00492798.v2.p1)
  • CONSENT - Consent group as determined by DAC (phv00492782.v1.p1)
  • HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00492800.v2.p1)
  • IS_TUMOR - Tumor status (phv00492799.v2.p1)
  • ONCOGENE - Driver oncogene inferred from baseline clinical NGS sequencing of tumor DNA (phv00492791.v1.p1)
  • PATIENT_ID - Patient ID (phv00492797.v2.p1)
  • PDL1_Status - Baseline percentage PD-L1 tumor proportion score (TPS) immunohistochemistry as assessed by clinical pathologist using 22C3 antibody methodology (phv00492792.v1.p1)
  • PRIMARY_METASTATIC_TUMOR - Primary tumor, metastasis, or transformed cell line (phv00492802.v2.p1)
  • Prior_therapy - Indicates the historical record of therapy received by a lung cancer patient prior to tumor resection (phv00492795.v1.p1)
  • SAMPLE_ID - Sample ID (phv00492796.v2.p1)
  • SAMPLE_ID - Sample ID for sequencing (phv00492785.v2.p1)
  • SAMPLE_TYPE - Type of sample (phv00492806.v2.p1)
  • SMOKING_PACKYEARS - A pack year is defined as twenty cigarettes smoked everyday for one year, over a subject's lifetime. (phv00492790.v1.p1)
  • SUBJECT_ID - Subject ID (phv00492786.v1.p1)
  • SUBJECT_ID - Subject ID (phv00492781.v1.p1)
  • SUBJECT_ID - Subject ID (phv00492784.v2.p1)
  • TIL_Infusion - Indicates whether patient ultimately received the TIL infusion product or not (phv00492794.v1.p1)
  • Tumor_Site - Location of metastasis resected (harvested) for genomics and TIL (tumor-infiltrating lymphocytes) (phv00492793.v1.p1)
  • TUMOR_STAGE - Tumor stage of sample by AJCC version 7 (phv00492803.v2.p1)
  • TUMOR_TREATMENT - Indicates the historical record of therapy received by a lung cancer patient prior to tumor resection (phv00492804.v2.p1)